2-(2,3-dicarboxycyclopropyl)glycine has been researched along with Psychotic Disorders in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barda, D; Britton, TC; Emkey, R; Hornback, WJ; Jagdmann, GE; Johnson, MP; McKinzie, DL; Nisenbaum, ES; Schoepp, DD; Tizzano, JP | 1 |
1 other study(ies) available for 2-(2,3-dicarboxycyclopropyl)glycine and Psychotic Disorders
Article | Year |
---|---|
Metabotropic glutamate 2 receptor potentiators: receptor modulation, frequency-dependent synaptic activity, and efficacy in preclinical anxiety and psychosis model(s).
Topics: Animals; Anxiety; Cyclopropanes; Excitatory Amino Acid Agonists; Excitatory Postsynaptic Potentials; Glycine; Humans; Male; Mice; Mice, Inbred DBA; Mice, Inbred ICR; Motor Activity; Phencyclidine; Psychotic Disorders; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Metabotropic Glutamate; Synaptic Transmission | 2005 |